RTALB.E Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS

Watchlist Manager

Watchlist

Price: 2.81 TRY -1.06% Market Closed

Market Cap: ₺1.4B

	RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS IST:RTALB.E	TR
S	Stryker Corp F:SYK	US

Profitability Summary

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS's profitability score is 47/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

35%

Sustainable 3Y Average Gross Margin

26%

Declining Gross Margin

35% > 35%

Negative Operating Margin

-5%

Negative 3Y Average Operating Margin

-35%

Operating Margin is Increasing

-37% > -5%

Exceptional Net Margin

128%

Strong 3Y Average Net Margin

120%

Declining Net Margin

524% > 128%

Exceptional Free Cash Flow Margin

49%

Negative 3Y Average Free Cash Flow Margin

-26%

Declining Free Cash Flow Margin

58% > 49%

Positive ROE

14%

Positive 3Y Average ROE

Negative 3Y Average ROIC

-2%

ROIC is Increasing

-4% > 0%

View All

Hide

Collapse

47 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.